Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)
Clinical trial NCT05112549 · RECRUITING
Trial details
- NCT number
- NCT05112549
- Sponsor
- University Hospital Tuebingen
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2026-12-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.